glycopyrrolate has been researched along with Depression, Involutional in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayeni, HA; Campbell, D; Chen, JCC; Hoeh, N; Muthukumaraswamy, SD; Naga, VK; Singh, V; Sumner, RL; Sundram, F; Wilson, A | 1 |
| Swartz, CM | 1 |
2 trial(s) available for glycopyrrolate and Depression, Involutional
| Article | Year |
|---|---|
A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder.
Topics: Antidepressive Agents; Australia; Bayes Theorem; Depressive Disorder, Major; Double-Blind Method; Glycopyrrolate; Humans; Scopolamine; Treatment Outcome | 2022 |
Physiological response to ECT stimulus dose.
Topics: Adjuvants, Anesthesia; Adult; Aged; Anesthetics, Intravenous; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroconvulsive Therapy; Electroencephalography; Female; Glycopyrrolate; Humans; Injections, Intramuscular; Male; Methohexital; Middle Aged; Neuromuscular Depolarizing Agents; Psychotic Disorders; Seizures; Succinylcholine; Tachycardia | 2000 |